Koo Kevin S H, Lamar David L, Shaw Dennis W W, Monroe Eric J, Shivaram Giridhar M
Section of Interventional Radiology, Department of Radiology, Seattle Children's Hospital, 4800 Sand Point Way NE, Seattle, WA 98105; Department of Radiology, University of Washington, Seattle, Washington.
Department of Radiology, University of Washington, Seattle, Washington.
J Vasc Interv Radiol. 2018 Nov;29(11):1578-1583. doi: 10.1016/j.jvir.2018.07.018. Epub 2018 Sep 17.
To describe safety and efficacy of catheter-directed thrombolysis (CDT) for portal vein thrombosis (PVT) in children.
Retrospective review was performed of 10 consecutive patients (7 girls, 3 boys; mean age 11.9 y; range, 3-17 y) with PVT undergoing CDT at a single tertiary children's hospital between August 2005 and March 2016. PVT was categorized by etiology and extent (intrahepatic, extrahepatic, or both). CDT was performed with infusion catheters placed via percutaneous transhepatic (PTH) and/or transjugular intrahepatic (TJ) approaches, with or without the use of adjunctive maneuvers, including balloon maceration and suction and rheolytic thrombectomy. Degree of thrombolysis on portal venography, presence of portal vein thrombus on available follow-up imaging, and complication rates were recorded.
In 10 patients, 13 CDT procedures were performed for PVT, with 3 patients requiring repeat CDT. Portal access was achieved with PTH (n = 6), TJ (n = 2), or combined (n = 2) approaches. All cases were successful in re-establishing patency and hepatopetal flow on portal venography with complete thrombolysis achieved in 10 of 13 cases (77%). Two major complications (20%) occurred, both with PTH access. Mean follow-up time for 9 patients was 2.6 years (range, 51-1,902 d) with long-term patency achieved in 6 (67%).
CDT can be safe and effective for PVT in children. Portal access considerations and early initiation of thrombolysis may further increase safety and efficacy.
描述儿童门静脉血栓形成(PVT)的导管直接溶栓(CDT)治疗的安全性和有效性。
对2005年8月至2016年3月期间在一家三级儿童医院接受CDT治疗的10例连续性PVT患儿(7例女孩,3例男孩;平均年龄11.9岁;范围3 - 17岁)进行回顾性研究。PVT按病因和范围(肝内、肝外或两者皆有)进行分类。CDT通过经皮经肝(PTH)和/或经颈静脉肝内(TJ)途径放置输注导管进行,使用或不使用辅助操作,包括球囊破碎、抽吸和血栓溶解切除术。记录门静脉造影的溶栓程度、可用随访成像上门静脉血栓的存在情况以及并发症发生率。
10例患者共进行了13次PVT的CDT治疗,3例患者需要重复CDT。通过PTH途径(n = 6)、TJ途径(n = 2)或联合途径(n = 2)实现门静脉通路。所有病例在门静脉造影上均成功重建通畅和向肝血流,13例中有10例(77%)实现了完全溶栓。发生了2例主要并发症(20%),均与PTH通路有关。9例患者的平均随访时间为2.6年(范围51 - 1902天),6例(67%)实现了长期通畅。
CDT治疗儿童PVT可能是安全有效的。门静脉通路的考虑因素和溶栓的早期启动可能会进一步提高安全性和有效性。